CORC

在结果中检索

CORC

浏览/检索结果: 共51条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Discovery of pyrimidine nucleoside dual prodrugs and pyrazine nucleosides as novel anti-HCV agents 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 卷号: 27, 期号: 5, 页码: 748-759
作者:  Guo, Shuang;  Xu, Mingshuo;  Guo, Qi;  Zhu, Fuqiang;  Jiang, Xiangrui
收藏  |  浏览/下载：39/0  |  提交时间：2020/07/01
Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infectionn 期刊论文
JOURNAL OF MEDICAL VIROLOGY, 2019, 卷号: 91, 期号: 7
作者:  Huang, Rui;  Rao, Huiying;  Xie, Qing;  Gao, Zhiliang;  Li, Wu
收藏  |  浏览/下载：22/0  |  提交时间：2019/12/04
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial 期刊论文
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 卷号: 4, 期号: 2
作者:  Li, Jun;  Jia, Jidong;  Hou, Jin Lin;  Mohamed, Rosmawati;  Duan, Zhongping
收藏  |  浏览/下载：44/0  |  提交时间：2019/12/05
Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial 期刊论文
The Lancet Gastroenterology & Hepatology, 2019, 卷号: Vol.4 No.2, 页码: 127-134
作者:  Lai Wei;  Seng Gee Lim;  Qing Xie;  Kính Nguyen Văn;  Teerha Piratvisuth
收藏  |  浏览/下载：42/0  |  提交时间：2019/02/25
Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial 期刊论文
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 卷号: 4, 期号: 2, 页码: 127-134
作者:  Wei, Lai;  Lim, Seng Gee;  Xie, Qing;  Kinh Nguyen Van;  Piratvisuth, Teerha
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/11
PAN-GENOTYPIC REGIMEN OF COBLOPASVIR PLUS SOFOSBUVIR FOR TREATMENT OF CHRONIC HEPATITIS C IN CHINA: A SINGLE-ARM, OPEN-LABEL, PHASE 3 TRIAL 会议论文
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, NOV 08-12, 2019
作者:  Gao, Yanhang;  Niu, Junqi;  Kong, Fei;  Li, Guangming;  Li, Cheng
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/31
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 卷号: 33, 期号: 6
作者:  Wei, Lai;  Xie, Qing;  Hou, Jin Lin;  Jia, Jidong;  Li, Wu
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/04
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study 期刊论文
HEPATOLOGY INTERNATIONAL, 2018, 卷号: 12, 期号: 2
作者:  Zhang, Fangqiu;  Wei, Lai;  Xie, Qing;  Hou, Jin Lin;  Tang, Hong
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial 期刊论文
HEPATOLOGY, 2018, 卷号: 68
作者:  Su, Minghua;  Duan, Zhongping;  Hou, Jinlin;  Jia, Jidong;  Dou, Xiaoguang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05
Pharmacokinetics, Safety, and Tolerability of the Direct-acting Hepatitis C Antiviral Sofosbuvir in Healthy Chinese Subjects 期刊论文
CLINICAL THERAPEUTICS, 2018, 卷号: 40, 期号: 9
作者:  Li, Xiaojiao;  Chen, Hong;  Niu, Junqi;  Chen, Guiling;  Shen, Gong
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace